Publicacions - Fundació Institut d'Investigació en Ciències de la

Casamitjana R,
Mallolas J, Pich J, Gatell JM; BICOMBO Study Team.
Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular
dysfunction.
AIDS 2010 Jan 28;24(3):F1-9.
IF: 6,348
Massanella M, Tural C, Papagno L, Garcia E, Jou A, Bofill M, Autran B, Clotet B, Blanco J.
Changes in T-cell subsets in HIV-HCV-coinfected patients during pegylated interferon-alpha 2a plus
ribavirin treatment
ANTIVIR THER 2010;15(3):333-42
IF: 4,322
Massanella, M; Negredo, E; Perez-Alvarez, N; Puig, J; Ruiz-Hernandez, R; Bofill, M; Clotet, B; Blanco, J
CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during
suppressive
HAART AIDS 2010; APR 24, 24 (7) 959-968
IF: 6,348
Moltó J, Deig E, Valle M, Llibre JM, Miranda C, Cedeño S, Valero S, Negredo E, Clotet B
Effect of Nevirapine on the Steady-State Trough Concentrations of Atazanavir in HIV-Infected Patients
Receiving Atazanavir/Ritonavir.
THER DRUG MONIT 2010 Feb;32(1):93-6
IF: 3,127
Moltó J, Sanz-Moreno J, Valle M, Cedeño S, Bonal J, Bouarich H, Clotet B.
Minimal Removal of Raltegravir by Hemodialysis in HIV-Infected Patients with End-Stage Renal Disease.
ANTIMICROB AGENTS CH 2010 Jul;54(7):3047-8
IF: 4,672
Moltó J, Valle M, Santos JR, Miranda C, Cedeño S, Negredo E, Yritia M, Videla S, Clotet B.
Efficacy and Safety of Ritonavir Dose Reduction Based on the Tipranavir Inhibitory Quotient in HIV-
Infected Patients on Salvage Antiretroviral Therapy With Tipranavir/Ritonavir
AIDS RES HUM RETROV 2010 Nov;26(11):1191-6. Epub 2010 Sep 23.
IF: 2,082
Moltó J, Valle M, Santos JR, Mothe B, Miranda C, Cedeño S, Negredo E, Yritia M, Videla S, Barbanoj MJ,
Clotet B.
Treatment simplification to once daily darunavir/ritonavir guided by the darunavir inhibitory quotient in
heavily pretreated HIV-infected patients.
ANTIVIR THER 2010;15(2):219-25
IF: 4,322
Munoz-Moreno, JA; Fumaz, CR; Prats, A; Ferrer, MJ; Negredo, E; Perez-Alvarez, N; Molto, J; Gomez, G;
Garolera, M; Clotet, B
Interruptions of antiretroviral therapy in human immunodeficiency virus infection: are they detrimental
to neurocognitive functioning?
J NEUROVIROL 2010; JUN, 16 (3) 208-218
IF: 2,243
Pàgina 60 de 148